PL356093A1 - Hydroksyeikozatetraeniany, sole, kompozycje i sposoby ich zastosowania w leczeniu zespołu suchego oka - Google Patents

Hydroksyeikozatetraeniany, sole, kompozycje i sposoby ich zastosowania w leczeniu zespołu suchego oka

Info

Publication number
PL356093A1
PL356093A1 PL00356093A PL35609300A PL356093A1 PL 356093 A1 PL356093 A1 PL 356093A1 PL 00356093 A PL00356093 A PL 00356093A PL 35609300 A PL35609300 A PL 35609300A PL 356093 A1 PL356093 A1 PL 356093A1
Authority
PL
Poland
Prior art keywords
hydroxyeicosatetraenoate
salts
compositions
methods
dry eye
Prior art date
Application number
PL00356093A
Other languages
English (en)
Inventor
L.Wayne Schneider
Raymond E. Conrow
Daniel A. Gamache
Terri Pasquine
John M. Yanni
Haresh G. Bhagat
Original Assignee
Alcon Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc. filed Critical Alcon Inc.
Publication of PL356093A1 publication Critical patent/PL356093A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL00356093A 1999-11-09 2000-10-23 Hydroksyeikozatetraeniany, sole, kompozycje i sposoby ich zastosowania w leczeniu zespołu suchego oka PL356093A1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16437099P 1999-11-09 1999-11-09
US16438499P 1999-11-09 1999-11-09
US16438299P 1999-11-09 1999-11-09
PCT/US2000/029227 WO2001034549A1 (en) 1999-11-09 2000-10-23 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders

Publications (1)

Publication Number Publication Date
PL356093A1 true PL356093A1 (pl) 2004-06-14

Family

ID=27389012

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00356093A PL356093A1 (pl) 1999-11-09 2000-10-23 Hydroksyeikozatetraeniany, sole, kompozycje i sposoby ich zastosowania w leczeniu zespołu suchego oka

Country Status (20)

Country Link
US (1) US6429227B1 (pl)
EP (1) EP1228028B1 (pl)
JP (1) JP2003513949A (pl)
KR (1) KR20020050240A (pl)
CN (1) CN1387503A (pl)
AR (1) AR032607A1 (pl)
AT (1) ATE301630T1 (pl)
AU (1) AU776187B2 (pl)
BR (1) BR0015436A (pl)
CA (1) CA2388044A1 (pl)
DE (1) DE60021908T2 (pl)
DK (1) DK1228028T3 (pl)
ES (1) ES2242643T3 (pl)
HK (1) HK1045302B (pl)
MX (1) MXPA02004701A (pl)
PL (1) PL356093A1 (pl)
PT (1) PT1228028E (pl)
TR (1) TR200201250T2 (pl)
TW (1) TWI283176B (pl)
WO (1) WO2001034549A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020077358A1 (en) * 2000-10-23 2002-06-20 Alcon Universal Ltd. Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
US20030109488A1 (en) * 2001-10-11 2003-06-12 Alcon, Inc. Methods for treating dry eye
US20030109508A1 (en) * 2001-10-11 2003-06-12 Alcon, Inc. Methods for treating dry eye
AU2003221715A1 (en) * 2002-06-14 2003-12-31 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat vaginal dryness
US20030232858A1 (en) * 2002-06-14 2003-12-18 Barker Ronnie C. Use of hydroxyeicosatetraenoic acid compounds to treat dry mouth
US6825232B2 (en) 2002-06-14 2004-11-30 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
AU2003221707A1 (en) * 2002-06-14 2003-12-31 Alcon, Inc. Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis
AU2003278727A1 (en) * 2002-09-20 2004-04-08 Alcon, Inc. Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
US7758883B2 (en) * 2002-10-18 2010-07-20 Aqueous Pharma Limited Three layer artificial tear formulation
US20050187192A1 (en) * 2004-02-20 2005-08-25 Kucera Pharmaceutical Company Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
EP2574341B1 (en) 2004-03-29 2017-03-29 University Of South Florida Effective treatment of tumors and cancer with triciribine phosphate
KR100642425B1 (ko) * 2004-07-09 2006-11-03 (유) 이도건설 친수호안 구조
EP1793836A4 (en) * 2004-10-01 2008-09-03 Richard L Lindstrom OPHTHALMIC COMPOSITIONS WITH LUBRICANTS, DETERMINANTS AND GLYCOSAMINOGLYCAN AND METHOD FOR THEIR USE
US7638142B2 (en) * 2005-10-12 2009-12-29 Vitamin Science, Inc. Therapeutic composition for the treatment of dry eye syndrome
WO2010064636A1 (ja) * 2008-12-02 2010-06-10 ロート製薬株式会社 眼科用組成物
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
ES2672238T3 (es) * 2011-01-26 2018-06-13 Allergan, Inc. Composición androgénica para el tratamiento de una afección oftálmica
IL212725A (en) * 2011-05-05 2016-06-30 Resdevco Res And Dev Co Glycerol Preparation for Non-surgical Conjunctivochalysis
CN104661682B (zh) * 2012-09-27 2018-05-11 千寿制药株式会社 水性液剂
PL3517100T3 (pl) * 2013-02-01 2021-04-19 Allergan, Inc. Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę
EP3878835A1 (en) * 2013-11-15 2021-09-15 DS Biopharma Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
IT202300019488A1 (it) * 2023-09-21 2025-03-21 D&V Farma Soc A Responsabilita Limitata Composizioni, usi e metodi per il trattamento della sindrome dell’occhio secco o per promuovere la guarigione delle ferite corneali

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991759A (en) 1975-10-28 1976-11-16 Alza Corporation Method and therapeutic system for treating aqueous deficient dry eye
US4131651A (en) 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
AU546872B2 (en) 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
US4421748A (en) 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid
GB8319073D0 (en) 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
US4868154A (en) 1986-02-19 1989-09-19 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with melanocyte stimulating hormones
US4753945A (en) 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4744980A (en) 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4818537A (en) 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4914088A (en) 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5278151A (en) 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US4921644A (en) 1988-02-29 1990-05-01 Technology Unlimited, Inc. Mucin directed lipsome
US4906467A (en) 1988-03-24 1990-03-06 New York Medical College Novel, long-duration treatment for glaucoma
US4923700A (en) 1988-06-03 1990-05-08 Kaufman Herbert E Artificial tear suspension
US5064655A (en) 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US5075104A (en) 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
WO1991012808A1 (en) 1990-02-22 1991-09-05 Macnaught Pty Limited Artificial tears
US5041434A (en) 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
ZA912797B (en) 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
DE69115990T2 (de) 1990-05-29 1996-05-30 Ocular Res Of Bonton Inc Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
US5102670A (en) 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
DE69212850T2 (de) 1991-01-15 1997-03-06 Alcon Lab Inc Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
EP0546728A3 (en) 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
CA2133966C (en) 1992-04-21 1997-09-09 David A. Sullivan Ocular androgen therapy in sjogren's syndrome
US5290572A (en) 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5358706A (en) 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5455265A (en) 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5389383A (en) 1993-06-18 1995-02-14 Allergan, Inc. Method for treating hypoxia-associated ocular complications
US5696166A (en) 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
CA2276267C (en) 1996-10-15 2009-12-22 The Liposome Company, Inc. Peptide-lipid conjugates, liposomes and liposomal drug delivery
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
WO2000051619A1 (en) 1999-03-01 2000-09-08 Vista Scientific Llc Mucin containing ophthalmic preparations

Also Published As

Publication number Publication date
DE60021908T2 (de) 2006-04-06
ATE301630T1 (de) 2005-08-15
US6429227B1 (en) 2002-08-06
CA2388044A1 (en) 2001-05-17
EP1228028A1 (en) 2002-08-07
JP2003513949A (ja) 2003-04-15
MXPA02004701A (es) 2004-09-10
BR0015436A (pt) 2002-07-16
DE60021908D1 (de) 2005-09-15
TWI283176B (en) 2007-07-01
HK1045302A1 (en) 2002-11-22
ES2242643T3 (es) 2005-11-16
EP1228028B1 (en) 2005-08-10
DK1228028T3 (da) 2005-11-14
KR20020050240A (ko) 2002-06-26
HK1045302B (en) 2005-10-14
AR032607A1 (es) 2003-11-19
CN1387503A (zh) 2002-12-25
AU1101401A (en) 2001-06-06
PT1228028E (pt) 2005-10-31
TR200201250T2 (tr) 2002-09-23
WO2001034549A1 (en) 2001-05-17
AU776187B2 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
PL356093A1 (pl) Hydroksyeikozatetraeniany, sole, kompozycje i sposoby ich zastosowania w leczeniu zespołu suchego oka
PL355998A1 (pl) Kompozycje zawierające pochodne kwasu hydroksyeikozatetraenowego oraz sposoby ich zastosowania w leczeniu zespołu suchego oka
PL343074A1 (en) Moistened cosmetic eye treatment pads
IL187513A0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
IL151946A0 (en) 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
WO2000038665A3 (en) Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
SI1575597T1 (sl) Uporaba rimeksolona pri zdravljenju suhega očesa
IL174593A0 (en) NOVEL TETRAHYDROSPIRO{PIPERIDINE-2,7'-PYRROLO[3,2-b]PYRIDINE} DERIVATIVES AND NOVEL INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF 5-HT6 RECEPTOR -RELATED DISORDERS
IL149496A0 (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU5774699A (en) Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
HUP0203806A3 (en) Hair treatment composition comprising cationic surfactants with cleansing and conditioning effect
IL156045A0 (en) Compositions containing gangliosides for use in the treatment of skin disorders
GB9820631D0 (en) Hair treatment composition, method and use
AU8031400A (en) 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
EP1589985A4 (en) METHOD AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISORDERS USING 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913 , 14303, 16816, 17827 OR 32620
AU2002358267A8 (en) Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
WO2001034552A3 (en) Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
GB0004534D0 (en) Hair treatment compositions and their use
HUP0105203A3 (en) S-nitrosothiols as agents for the treatment of circulatory dysfunctions and their use
PL356105A1 (pl) Analogi kwasu hydroksyeikozatetraenowego oraz sposoby ich zastosowania do leczenia zespołu suchego oka
EP1517912A4 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISEASES USING GENES 577, 20739 OR 57145

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)